Microcap Ledger

Tickers · $TKNO

Alpha Teknova, Inc. $TKNO

By Microcap Ledger desk · CIK 0001850902

Facts as of . Built from SEC filings and our own data. Small caps move fast; check the latest filings.

Snapshot

Exchange
Nasdaq Global Market
Sector
In Vitro & In Vivo Diagnostic Substances
Headquarters
Hollister, CA
Fiscal year end
December 31
Shares outstanding
53,688,246 [10-Q 2026-08-06]
as of 2026-08-05

Sources: [10-K 2026-03-02]

What the company doesAI summary of filing

Alpha Teknova is a revenue-generating manufacturer of chemical reagents and culture media used in life sciences research, drug development, and manufacturing. The company produces three primary product types—pre-poured media plates, liquid microbial culture media and supplements, and molecular biology reagents—sold under two categories: Lab Essentials (research-grade products representing 76.6% of 2025 revenue) and Clinical Solutions (GMP-grade products representing 18.9% of 2025 revenue). It serves over 3,000 customers including pharmaceutical and biotechnology companies, contract manufacturers, diagnostic companies, and academic institutions, with approximately 95% customer retention among accounts spending over $10,000 annually. The company manufactures custom and catalog formulations at its facilities in Hollister, California, and generated revenue in the year ended December 31, 2025, though it reported a net loss of $17.3 million for that period. [10-K 2026-03-02]

Segments: Lab Essentials, Clinical Solutions, Pre-poured Media Plates, Liquid Microbial Culture Media and Supplements

Financial health

From XBRL company facts (USD)
PeriodRevenueNet incomeOperating cash flowCashFiling
6 months to Jun 2026$23.26M−$7.72M −$3.83M$6.00M[10-Q 2026-08-06]
FY ended Dec 2025$40.52M−$17.26M −$8.65M$5.91M[10-K 2026-03-02]
FY ended Dec 2024$37.74M−$26.75M −$12.39M$3.71M[10-K 2026-03-02]
Quarterly cash burn
−$1.92M
Cash runway Estimate
~9.4 months

Estimate: cash at the end of the period (6 months to Jun 2026) divided by the average monthly operating cash outflow over that period. Ignores any cash raised or spent since, and any financing.

Capital structure and dilution

Summary only. How these instruments work: Dilution & financing desk.

Share count
DateShares outstandingFiling
2024-11-0753,307,689[10-Q 2024-11-08]
2025-03-0553,436,806[10-K 2025-03-07]
2025-05-0753,440,810[10-Q 2025-05-09]
2025-08-0653,515,167[10-Q 2025-08-08]
2025-11-0553,529,174[10-Q 2025-11-07]
2026-02-2753,587,662[10-K 2026-03-02]
2026-05-0553,614,028[10-Q 2026-05-07]
2026-08-0553,688,246[10-Q 2026-08-06]
Shelf registration
S-3 filed 2025-07-10; declared effective 2025-07-16 [S-3 2025-07-10]

Listing status

Current status: No Form 8-K Item 3.01 (listing notice) filings in the last 24 months, as of 2026-10-11.

More on deficiency notices and uplistings: Listing status desk.

Who owns it

Recent Form 4 transactions
DateInsiderTypeSharesPriceFiling
2026-07-14Demski Martha Jother12,000—[4 2026-07-16]
2026-07-14Demski Martha Jother12,000—[4 2026-07-16]
2026-03-06Lowell Matthewbuy40,000$2.19[4 2026-03-09]
2026-03-06Gunstream Stephenbuy26,000$2.15[4 2026-03-09]

Catalysts and calendar

Recent filings and releases
DateTypeTitle
2026-08-0610-QQuarterly report
2026-08-058-KResults of operations
2026-06-018-KDirector or officer change; Shareholder vote results
2026-05-0710-QQuarterly report
2026-05-068-KResults of operations
2026-04-21DEF 14AProxy statement
2026-03-0210-KAnnual report
2026-02-268-KResults of operations
2025-11-0710-QQuarterly report
2025-11-068-KResults of operations

Facts as of . Small caps move fast; check the latest filings.